Radioligand
Therapy
Academy

The RLT Academy project aims to promote education of radioligand therapies in Europe and bridge the educational gap among healthcare professionals.

In collaboration wih 14 organisations

What is Radioligand Therapy

Radioligand therapy (RLT) is an innovative approach to cancer treatment that delivers radiation directly to tumour cells (with the help of radioisotopes), regardless of where they are inside the body, while minimising the damage to all the healthy tissue that surrounds the tumour cells.
It is a major milestone in cancer therapy.

Our Objectives

MAP

the knowledge gap in RLTs

BRIDGE

the knowledge gap that currently exists among healthcare professionals

PROMOTE

the integration of RLTs into mainstream cancer care

Current Landscape of RLT in Europe

We performed a systematic survey to assess the existing gaps in Europe in multidisciplinary education for integration of radioligand therapy (RLT) into cancer care and to obtain detailed information on the current limitations and key contents relevant.

A high-quality questionnaire, with emphasis on survey scales, formulation, and validity of the different items, was designed. An expert validation process was undertaken. The survey was circulated among medical specialties involved in cancer treatment, universities, and nursing organizations.

Courses and fellowships

Basic RLT course

Access: Open

Online course

Advanced RLT course

Access: Open with prerequisites

Online course – currently inactive

Professional RLT course

Access: Open with prerequisites

Online course – currently inactive

Short fellowship

Access: Open with prerequisites

Fellowship – currently inactive

Long fellowship

Access: Open with prerequisites

Fellowship – currently inactive

Consortium Members and Professors

Christophe Deroose

Professor Nuclear Medicine – KU Leuven, RLT Academy Consortium leader

Paola Anna Erba

Scientific Coordinator of European Association of Nuclear Medicine (EANM)

Christian la Fougère

Medical Director, University Hospital and Faculty of Medicine Tübingen, Germany

Ken Herrmann

Board certified Nuclear Medicine physician, theranostic expert, focus on translation of innovative theranostic concepts

Ignasi Carrio

Radiology and Nuclear Medicine

Irene A. Burger

Oncology hybrid imaging, focus on prostate cancer